| | SUICIDE AS AN INDICATOR OF QUALITY OF LIFE: EVIDENCE FROM DIALYSIS PATIENTS JON M. FORD and DAVID L. KASERMAN * Quality of life has been measured in many different ways for patients with chronic medical conditions. What is unique about the approach used here is that it uses suicide rates as a relatively objective measure of quality of life within the population of dialysis patients. Using a Heckman selection model, we estimate the relative suicide rates across patients undergoing both hemodialysis and petitoneal dialysis. Our empirical results show that patients on hemodialysis have relatively lower suicide rates after controlling for other factors. Specifically, our results indicate that 141 fewer suicides will occur for every 1,000 patients shifted from peritoneal to hemodialysis. Prior estimates of the higher costs of the latter modality yield an estimated expenditure of $42,043 per suicide avoided. ( JEL118, L84, 131) I. INTRODUCTION Cost considerations have always played an important role in policy debates in the medical industry, and that role promises to grow as funding agencies' budgets are subjected to increasing scrutiny. Costs alone, however, cannot be the sole determining factor in resource allocation decisions in this sector of the economy. Rational choice requires that other pertinent factors be weighed in the analysis of alternative uses of limited funds. Among these other factors, quality of life considerations stand out as one of the more important components of optimal funding decisions. 1 As with any other index of an individual's level of utility, the concept of quality of life is highly subjective. Despite such subjectivity, in most product markets (e.g., cars, houses, and clothes) willingness to pay metrics are estimable from observed purchase behavior. Objective measurement of willingness to pay, however, is particularly problematic in many health care markets because, in many cases, patients do not pay directly (or often even indirectly) for the services they receive. Most of the cost of treatment is paid by third parties. This feature, of course, is also true for many goods that are publicly provided, like recreation in national forests and use of publicly provided highways. In the case of recreation and highways, however, proxies can be used to approximate willingness to pay. To be sure, such proxies are imperfect, but they provide some relevant information. 2 | ABBREVIATIONS | | ESRD: End Stage Renal Disease | | 2SLS: Two-Stage Least Squares | | USRDS: U.S. Renal Data System | ____________________ | * | We gratefully acknowledge the comments provided by Randy Beard, Steve Caudill, Charles Diskin, Bob Ekelund, and John Jackson. In addition, the suggestions of two anonymous referees and Robert Michaels have also improved the paper. The usual caveat applies. This topic was first addressed in Ford's doctoral dissertation, titled Four Essays on the Dialysis Industry, completed on June 10, 1996 , at Auburn University. Ford and Kaserman: Department of Economics, Auburn University, Auburn, AL 36849-5242, Phone 1-334844-2905, Fax 1-334-844-4615, E-mail kaserman@ business.auburn.edu | | 1 | For example, a recent issue of The DOPPS Report ( 1999 , p. 4), which is a newsletter providing ongoing reports regarding a large international study of dialysis patients and facilities in seven countries, states: "While mortality is of primary interest, there is increasing concurrence among renal researchers and health care providers that the quality of dialysis care cannot be measured in terms of survival only. . . . Consequently, a study as comprehensive as DOPPS needs to include study objectives that focus on patient quality of life and well-being." | | 2 | See, for example, Just et al. (1982), chapters 6 and 12, for a discussion of these issues. | -440- | |